Association of day-case rates with post COVID-19 recovery of elective laparoscopic cholecystectomy activity across England.

Association of day-case rates with post COVID-19 recovery of elective laparoscopic cholecystectomy activity across England.

Publication date: Apr 02, 2024

The aim of this study was to investigate the safety of day-case laparoscopic cholecystectomy, and the association between day-case rates and, post the COVID-19 pandemic, recovery of activity to prepandemic levels for integrated care boards (ICBs) in England. This was a retrospective observational study of the Hospital Episodes Statistics (HES) data set. Elective laparoscopic cholecystectomies for the period 1 January 2019 to 31 December 2022 were identified. Activity levels for 2022 were compared with those for the whole of 2019 (baseline). Day-case activity was identified where the length of stay recorded in the HES was zero days. Data were available for 184,252 patients across the 42 ICBs in England, of which 120,408 (65. 3%) were day-case procedures. By December 2022, activity levels for the whole of England had returned to 88. 2% of prepandemic levels. The South West region stood out as having recovered activity levels to the greatest extent, with activity at 97. 3% of prepandemic levels during 2022. The South West also had the highest postpandemic day-case rate at 74. 9% of all patients seen as a day-case during 2022; this compares with an England average of 65. 3%. At an ICB level, there was a significant correlation between day-case rates and postpandemic activity levels (r = 0. 362, p = 0. 019). There was no strong or consistent evidence that day-case surgery had poorer patient outcomes than inpatient surgery. Recovery of elective laparoscopic cholecystectomy activity has been better in South West England than in other regions. Increasing day-case rates may be important if ICBs in other regions are to increase activity levels up to and beyond prepandemic levels.

Concepts Keywords
Cholecystectomy COVID-19
December Day-case surgery
Postpandemic General surgery
Statistics Laparoscopic cholecystectomy

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Hydroxyethyl Starch
disease VO data set
drug DRUGBANK Tropicamide

Original Article

(Visited 1 times, 1 visits today)